SANKYO C25 (Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg)
Pill with imprint SANKYO C25 is Pink, Elliptical / Oval and has been identified as Hydrochlorothiazide and Olmesartan Medoxomil 25 mg / 40 mg. It is supplied by Sun Pharmaceutical Industries Inc..
Hydrochlorothiazide/olmesartan is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/olmesartan 25 mg / 40 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SANKYO C25
Hydrochlorothiazide and Olmesartan Medoxomil
- Imprint:
- SANKYO C25
- Strength:
- 25 mg / 40 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC):
- 57664-0760
More about hydrochlorothiazide/olmesartan
- Hydrochlorothiazide/olmesartan Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 29 Reviews
- Drug class: angiotensin II inhibitors with thiazides
Consumer resources
- Hydrochlorothiazide and olmesartan
- Olmesartan and Hydrochlorothiazide
- Olmesartan and hydrochlorothiazide (Advanced Reading)
Other brands: Benicar HCT
Professional resources
- Olmesartan Medoxomil and Hydrochlorothiazide (FDA)
- Olmesartan and Hydrochlorothiazide (Wolters Kluwer)
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
